The Role of Innate Immunity in Graft-Versus-Host Disease and Complications following Allogeneic Stem Cell Transplant
Open Access
- 31 January 2009
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (1), 59-61
- https://doi.org/10.1016/j.bbmt.2008.10.008
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell wallsCellular Microbiology, 2008
- Caspase-1 inflammasomes in infection and inflammationJournal of Leukocyte Biology, 2007
- Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2005
- Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- B activation: common genetic etiology with Blau syndromeBlood, 2004
- NODs: intracellular proteins involved in inflammation and apoptosisNature Reviews Immunology, 2003
- NALPs: a novel protein family involved in inflammationNature Reviews Molecular Cell Biology, 2003
- LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationJournal of Clinical Investigation, 2001
- Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplantsAmerican Journal Of Medicine, 1984
- Role of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host ReactionJNCI Journal of the National Cancer Institute, 1977
- Mitigation of Secondary Disease of Allogeneic Mouse Radiation Chimeras by Modification of the Intestinal MicrofloraJNCI Journal of the National Cancer Institute, 1974